Herbalife Ltd. (NYSE:HLF) director Donal L. Mulligan has increased his stake in the company, purchasing $289,500 worth of common stock, a recent SEC filing shows. Mulligan, who serves on the board of the global nutrition company, made the purchase on May 3 at a price of $9.65 per share, adding 30,000 shares to his holdings. This transaction brings his total ownership to 60,000 shares held indirectly through a trust.
The buy comes at a time when Herbalife's stock has seen various fluctuations, and such investments by directors are often seen as a sign of confidence in the company's future prospects. Alongside the purchase, Mulligan also acquired 15,657 restricted stock units (RSUs) under the company's 2023 Stock Incentive Plan, which will fully vest on April 15, 2025, contingent upon his continued service on the board.
Investors often keep a close eye on insider transactions as they provide insights into the sentiment of those who are closely involved with the company's operations and strategy. Mulligan's recent buy could be interpreted as a positive signal to the market, reflecting an insider's belief in the value of the stock.
Herbalife Ltd. specializes in nutritional supplements and operates on a global scale, with its shares traded on the New York Stock Exchange. The company has been the subject of much attention from investors and the media in recent years, making insider transactions like Mulligan's all the more noteworthy.
The details of the transactions were made public in the mandatory filings with the Securities and Exchange Commission. The filing was signed by Alaaeddine Sahibi, as Attorney-In-Fact for Donal L. Mulligan, on May 6.
InvestingPro Insights
As Herbalife Ltd. (NYSE:HLF) director Donal L. Mulligan increases his stake in the company, the latest data and insights from InvestingPro offer a broader context for investors considering the stock's potential. Herbalife's market cap stands at a modest $961.69 million, and the stock is trading at a low earnings multiple, with a P/E ratio of just 6.91. This valuation is even more attractive when considering the adjusted P/E ratio for the last twelve months as of Q1 2024, which is 5.98.
InvestingPro Tips highlight that analysts have recently revised their earnings expectations downwards for the upcoming period. Meanwhile, the stock has experienced a significant return over the last week, with a 7.88% price total return, and a strong return over the last month at 21.88%. This short-term performance contrasts with a more challenging half-year period, where the stock has taken a notable hit, reflected by a 30.48% price total return over the last six months.
For investors seeking further insights and tips, there are additional InvestingPro Tips available, which might shed light on the company's future performance and stock valuation. With the provided coupon code PRONEWS24, investors can get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro. This could be a valuable resource for those looking to delve deeper into Herbalife's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.